Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Journal of clinical oncology, 2015-12, Vol.33 (34), p.4015-4022 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.62.3397 ;PMID: 26351349
Full text available